Stock comparison
AbbVie Inc. is 3.5x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($440.14 B vs $126.01 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 3.5x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($440.14 B vs $126.01 B).
Market value leader
ABBV
AbbVie Inc. is 3.5x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($440.14 B vs $126.01 B).
Revenue leader
ABBV
VRTX: $12.00B vs ABBV: $61.16B.
Profit leader
ABBV
VRTX: $3.95B vs ABBV: $4.23B.
Margin leader
VRTX
VRTX: 32.9% vs ABBV: 6.9% net margin.
| Metric | VRTX | ABBV |
|---|---|---|
| Market cap | $126.01 B | $440.14 B |
| US-listed rank | #123 | #25 |
| Revenue (latest FY) | $12.00B | $61.16B |
| Net income (latest FY) | $3.95B | $4.23B |
| Net margin | 32.9% | 6.9% |
| P/E (trailing FY) | 31.9x | 104.2x |
| SEC filings | 1,000 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 3.5x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($440.14 B vs $126.01 B).
In their latest fiscal years, VERTEX PHARMACEUTICALS INC / MA reported $12.00B in revenue while AbbVie Inc. reported $61.16B.
Full pages: VERTEX PHARMACEUTICALS INC / MA and AbbVie Inc., or browse the full rankings.